期刊文献+

浅谈胃肠道间质瘤外科治疗临床分析

原文传递
导出
摘要 目的:探讨不同手术方式对胃肠道间质瘤(GlST)预后的影响。方法:回顾性分析我科1995年1月至2010年2月间收治的48例GIST患者的临床病理资料,根据手术方式不同分为2组:A组为行肿瘤局部切除者26例;B组为肿瘤所在器官大部或全切除者22例。对2组病例进行随访,分别计算中住生存期,1年、2年和5年生存率,并对z组数据进行比较。结果:A组26例中25例获得随访,中住生存时问43个月;B组22例均获得随访,中位生存时间44个月,2组比较,P〉0.05。A组1年、2年和5年生存率分别为92.6%、83.6%和73.3%;B组为91.5%、81.7%和71.6%,2组比较,差异无显著性,P〉0.05。按照Fletcher分级,高度风险分级的GIST患者采用肿瘤所在器官大部或全切除者较行肿瘤局部切除者中位生存时间长及生存率高,P〈0.05。结论:完整手术切除是治疗GIST的最好方法,但按照Fletcher分级,高度风险分级的GIST患者应采用肿瘤所在器官大部或全切除。
作者 魏曦
出处 《按摩与康复医学》 2011年第21期134-135,共2页 Chinese Manipulation and Rehabilitation Medicine
  • 相关文献

参考文献11

  • 1Mazur MT, Clark HB. Gastric stromal tumors: Reap--praisal ofhistogenesis[J]. Am J Surg Pathol,1983 Sept7(6) : 507--519.
  • 2Fletcher CD, Berman J J, Corless C, et aI. Diagnosis of gastrointesti- nal stromal tumors: a consensus approach[J]. Int J Surg Pathol, 2002,10(2): 81-89.
  • 3Trent JC,Ben]amin RS. New developments in gastrointestinal stroreal tumor. Curr Opin Oncol,2006,18(4) : 386--395.
  • 4Hassan I,You YN, Shyyan R,et al. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis[J]. Ann Surg Oncol,2008,15(1) :52-59.
  • 5Tsukuda K, Hirai R,Miyake T, et ak The outcome of gastrointestinal stromal tumors(GISTs)after a surgical resection in our institute[J]. Surg Today,2007,37(11) : 953-957.
  • 6Dematteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival[J]. Ann Surg, 2000,231 (1) : 51 - 58.
  • 7Langer C,Gunawan B, Schuler P, et al. Prognostic factors influen- cing surgical management and outcome of gastrointestinal stromal tumors[J]. Br J Surg, 2003,90(3) : 332- 339.
  • 8万德森,伍小军,梁小曼,罗容珍,潘志忠,陈功,卢震海,丁培荣.胃肠道间质瘤的外科治疗[J].中华胃肠外科杂志,2003,6(5):288-291. 被引量:48
  • 9张威,邵钦树,叶再元,赵仲生,王跃东,竺扬文.原发性胃肠道间质瘤73例的外科治疗[J].中华外科杂志,2009,47(2):98-101. 被引量:5
  • 10沈坤堂,侯英勇,秦新裕,宋陆军,宿杰阿克苏.甲磺酸伊马替尼靶向治疗晚期胃肠道间质瘤[J].中华胃肠外科杂志,2005,8(2):129-131. 被引量:12

二级参考文献52

  • 1竺杨文,王跃东,李保军.胃肠道间质瘤的腹腔镜外科治疗[J].外科理论与实践,2004,9(6):506-507. 被引量:8
  • 2Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol, 1983,7:507-519.
  • 3Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach : a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Patho1,2005 ,29 :52-68.
  • 4Candelaria M, de la Garza J, Duenas-Gonzalez A. A clinical and biological overview of gastrointestinal stromal tumors. Med Oncol, 2005,22 : 1-10.
  • 5Raccah E, Merimsky O, Kuten A, et al. Imatinib mesylate (glivec) as a treatment for gastrointestinal stromal tumor (GIST)-long term follow-up. Harefuah ,2007,146:329-334.
  • 6Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int J Surg Pathol,2002,10:81-89.
  • 7Hassan I, You YN, Shyyan R, et al. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Ann Surg 0ncol,2008,15:52-59.
  • 8Tsukuda K,Hirai R, Miyake T, et al. The outcome of gastrointestinal stromal tumors (GISTs) after a surgical resection in our institute. Surg Today ,2007,37:953-957.
  • 9Dematteo RP, Gold JS, Saran L, et al. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer, 2008, 112:608-615.
  • 10Blay JY, Bonvalot S, Casali P, et al. Consensus meeting for the management of gastrointestinal stromal tumors. Ann 0ncol,2005, 16:566-578.

共引文献141

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部